← BIO-TECHNE Corp TECH
Market Price
$72.42
Market Cap
$11.30B
P/E Ratio
157.42
Revenue (FY 2025)
↑5.2% YoY
$1.22B
3-Yr CAGR: 3.3%
Net Income
↓-56.3% YoY
$73.40M
Net Margin: 6.0%
Free Cash Flow
↑8.7% YoY
$256.55M
FCF Yield: 2.27%
EPS (Diluted)
↓-56.2% YoY
$0.46
Basic: $0.47
Return on Equity
Efficiency
3.5%
ROA: 12.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TECH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $499.0M | — | $336.7M | $104.5M | — | $2.80 | — | $143.9M | $127.0M | — |
| FY 2017 | $563.0M | +12.8% | $374.5M | $76.1M | -27.2% | $2.03 | -27.5% | $143.4M | $128.3M | +1.0% |
| FY 2018 | $643.0M | +14.2% | $432.1M | $126.2M | +65.8% | $3.31 | +63.1% | $170.4M | $149.4M | +16.5% |
| FY 2019 | $714.0M | +11.0% | $473.5M | $96.1M | -23.8% | $2.47 | -25.4% | $181.6M | $156.2M | +4.5% |
| FY 2020 | $738.7M | +3.5% | $483.2M | $229.3M | +138.7% | $5.82 | +135.6% | $205.2M | $153.5M | -1.8% |
| FY 2021 | $931.0M | +26.0% | $632.9M | $140.4M | -38.8% | $3.47 | -40.4% | $352.2M | $307.9M | +100.6% |
| FY 2022 | $1,105.6M | +18.7% | $756.5M | $272.1M | +93.8% | $6.63 | +91.1% | $325.3M | $280.4M | -8.9% |
| FY 2023 | $1,136.7M | +2.8% | $769.8M | $285.3M | +4.9% | $1.76 | -73.5% | $254.4M | $216.1M | -22.9% |
| FY 2024 | $1,159.1M | +2.0% | $769.7M | $168.1M | -41.1% | $1.05 | -40.3% | $299.0M | $236.1M | +9.2% |
| FY 2025 | $1,219.6M | +5.2% | $790.3M | $73.4M | -56.3% | $0.46 | -56.2% | $287.6M | $256.6M | +8.7% |
Valuation
Market Price
$72.42
Market Cap
$11.30B
Enterprise Value
N/A
P/E Ratio
157.42
P/B Ratio
5.48
FCF Yield
2.27%
Dividend Yield
0.44%
Shares Outstanding
Profitability & Margins
Gross Margin
64.80%
Operating Margin
8.38%
Net Margin
6.02%
Return on Equity (ROE)
3.55%
Return on Assets (ROA)
12.07%
Asset Turnover
2.00x
Revenue 3-Yr CAGR
3.33%
Financial Health & Liquidity
Current Ratio
23.70
Cash Ratio
6.32
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$162.19M
Total Debt
N/A
Book Value / Share
$13.21
Cash Flow Efficiency
Operating Cash Flow
$287.56M
Capital Expenditures (CapEx)
$31.01M
Free Cash Flow
$256.55M
OCF / Revenue
23.58%
FCF / Revenue
21.03%
FCF 3-Yr CAGR
-2.92%
Per Share Metrics
EPS (Diluted)
$0.46
EPS (Basic)
$0.47
Dividends / Share
$0.32
Book Value / Share
$13.21
EPS YoY Growth
-56.19%
Balance Sheet (FY 2025)
Total Assets
$608.30M
Total Liabilities
$25.66M
Stockholders' Equity
$2.07B
Current Assets
$608.30M
Current Liabilities
$25.66M